Seyed Seifollah Beladi Mousavi
1, Hamid Nasri
2, Mahmoud Rafieian-Kopaei
3*, Mohamad-Reza Tamadon
41 Department of Internal Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran
3 Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
4 Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran
*Corresponding Author: *Corresponding author: Prof. Mahmoud Rafieian-kopaei, Medical Plants Research Center, Shahrekord University of Medical Sciences, Sharekord, Iran., Email:
rafieian@yahoo.com
Implication for health policy/practice/research/medical education
It is acceptable to interpret that metformin has three different responsibilities including: blood glucose regulatory effect, renal tubular cell protection by acting as an effective antioxidant and finally protective effect on diabetic nephropathy through saving the podocytes. Hence, diabetic patients may benefit from all of these three distinct ameliorative effects.
Please cite this paper as:
Beladi Mousavi SS, Nasri H, Rafieian-Kopaei M, Tamadon MR. Metformin improves diabetic kidney disease. J Nephropharmacol 2012; 1(1): 1-2.